NEWS: Biotech IPO success--molecular evolution

Max More (max@maxmore.com)
Thu, 16 Dec 1999 13:39:26 -0800

Rather unusually for a biotech IPO, today Maxygen went public very successfully. They are using directed molecular evolution. The founder has also co-founded several other successful companies including Affymetrix. Full story:

http://www.cnbc.com/commentary/commentary_full_story_stocks.asp?StoryID=9836

Max